30 Participants Needed

Biosensors for Rett Syndrome

(VIBRANT Trial)

Recruiting at 3 trial locations
Jv
JR
Overseen ByJennifer Reynolds
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Rett Syndrome Research Trust
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests wearable biosensors to track symptoms such as heart rate, breathing, sleep, blood oxygen levels, and movement in individuals with Rett syndrome. The goal is to determine if these devices can accurately measure symptoms at home and during an overnight sleep study. Participants with Rett syndrome who have a specific genetic variant and access to WiFi might be suitable, provided they can sleep alone and are not taking certain heart-related medications. The study also examines the ease of use of these devices for families. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance symptom tracking for Rett syndrome.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on using innovative biosensors to track autonomic symptoms in individuals with Rett syndrome. Unlike traditional methods, which often rely on subjective symptom reporting or intermittent clinical assessments, these biosensors provide continuous, real-time monitoring of physiological signals. This approach could lead to more accurate and timely detection of symptom changes, potentially improving patient management and quality of life. By offering a more precise method of tracking symptoms, researchers hope to gain deeper insights into the condition and tailor treatments more effectively.

Are You a Good Fit for This Trial?

Inclusion Criteria

I have access to WiFi.
I have Rett syndrome caused by a MECP2 genetic change.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Biosensor Use

Participants use wearable and non-wearable biosensors intermittently at home to collect symptom data

4-9 weeks
Intermittent home use

Overnight Sleep Study

Participants undergo an overnight sleep study to compare biosensor data with PSG data

1 night
1 visit (in-person)

Follow-up

Participants are monitored for the accuracy and reliability of biosensor data compared to PSG data

4 weeks

Custom Device Schedule (Optional)

A cohort of participants may enroll in a custom device schedule for up to 1 year

Up to 1 year

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rett Syndrome Research Trust

Lead Sponsor

Trials
8
Recruited
5,400+